Published Date: 16 Mar 2023
Avascular necrosis (AVN) is considered an iatrogenic complication after treatment for progressive hip dysplasia, but research in China has revealed two characteristics associated with this condition. ossification nuclei.
Read Full NewsDavid Tom Cooke, MD, reviewed the importance of shared decision making as it relates to risk and benefit of cancer screening, as well as in more refined invasive care options.
Friedberg explains how an emphasis on physical fitness prior to and after surgery can significantly better long-term outcomes.
Bakhos explains the ideal patient population and strategies inherent to LVRS success.
The chief medical officer at the Parkinson’s Foundation detailed how mood and behavioral symptoms shape quality of life in Parkinson disease and how clinicians can better identify and manage them.
IntraBio reported that levacetylleucine showed symptom improvement in the phase 3 IB1001-303 study for ataxia-telangiectasia, and it intends to proceed with regulatory submissions in multiple regions.
A Phase 1 study in healthy lactating women found that a single 10‑mg dose of zavegepant nasal spray was generally safe, well tolerated, and resulted in minimal infant exposure through breast milk.
Julie Khlevner, MD, AGAF, highlights that FDA approval of linaclotide provides the first pharmacologic therapy for pediatric IBS-C.
1.
After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Breast cancer: A new target to eliminate dormant cells before they wake
4.
Novel Agent Effective for Cancer Wasting Disorder
5.
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists
1.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
2.
Breaking Down the Different Types of Lymphoma: What You Need to Know
3.
CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review
4.
A New Perspective on Spherocytosis: Uncovering Innovative Treatments
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
2.
Updates on the First Line Management of ALK+ NSCLC
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
5.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation